February 2024
1. DONG X, Du L, Luo Z, Xu Y, et al
   Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort study.
   PLoS Med. 2024;21:e1004340.
   

   >> Share

   
   October 2023
2. GONZALEZ-LOPEZ N, Quintero E, Gimeno-Garcia AZ, Bujanda L, et al
   Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study).
   PLoS Med. 2023;20:e1004298.
   

   >> Share

   
   October 2022
3. PETROVA D, Spacirova Z, Fernandez-Martinez NF, Ching-Lopez A, et al
   The patient, diagnostic, and treatment intervals in adult patients with cancer from high- and lower-income countries: A systematic review and meta-analysis.
   PLoS Med. 2022;19:e1004110.
   

   >> Share

   
   February 2022
4. GILL D, Burgess S
   The evolution of mendelian randomization for investigating drug effects.
   PLoS Med. 2022;19:e1003898.
   

   >> Share

   
   
5. HAO S, Snyder RA, Irish W, Parikh AA, et al
   Correction: Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.
   PLoS Med. 2022;19:e1003937.
   

   >> Share

   
   October 2021
6. HAO S, Snyder RA, Irish W, Parikh AA, et al
   Association of race and health insurance in treatment disparities of colon cancer: A retrospective analysis utilizing a national population database in the United States.
   PLoS Med. 2021;18:e1003842.
   

   >> Share

   
   
7. ODENY B
   Cancer Special Issue: Early detection and minimal residual disease.
   PLoS Med. 2021;18:e1003794.
   

   >> Share

   
   
8. ABBOSH C, Swanton C
   ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
   PLoS Med. 2021;18:e1003771.
   

   >> Share

   
   August 2021
9. WANG Y, Yang L, Bao H, Fan X, et al
   Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
   PLoS Med. 2021;18:e1003741.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share